Biolidics Ltd
SGX:8YY
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
| Country | Company | Market Cap | ROE | ||
|---|---|---|---|---|---|
| SG |
|
Biolidics Ltd
SGX:8YY
|
38.1m SGD |
2 638%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
237.7B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
159.3B USD |
16%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
144.5B USD |
14%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
143.6B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
121.3B USD |
9%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
12%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
53.5B USD |
6%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD |
65%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
43.2B USD |
47%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
40.2B USD |
26%
|
Biolidics Ltd
Glance View
Biolidics Ltd. operates as a medical technology company. The firm is primarily engaged in the research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics-related industrial design services and investment holdings. The company segments include cancer, infectious diseases and laboratory services. The cancer segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the cancer field. The infectious diseases segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the infectious diseases field. The laboratory services segment involves the business, operation and provision of laboratory services to customers.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on Biolidics Ltd's most recent financial statements, the company has ROE of 2 638.5%.
You don't have any saved screeners yet